Literature DB >> 12454137

M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999.

Gregory J Tyrrell1, Marguerite Lovgren, Betty Forwick, Nancy P Hoe, James M Musser, James A Talbot.   

Abstract

The National Centre for Streptococcus (NCS) (Canada) determined the group A streptococcal (GAS) M types of 4,760 Canadian isolates submitted between 1993 and 1999 by classic serotyping. The 10 most frequently identified M types were M1 (26.4%), M12 (9.8%), M28 (8.9%), M3 (6.8%), M4 (6.2%), M11 (4.8%), M89 (3.1%), M6 (3.0%), M2 (2.6%), and M77 (1.9%). Nontypeable isolates accounted for 15.4% of the collection. The province of Ontario submitted 51.1% of the isolates, followed by Quebec (21.2%) and Alberta (13.9%). Together, these three provinces constituted 71.3% of the Canadian population in 1996. The numbers of M types M1, M12, M28, and M3 occurred most frequently in subjects whose ages were <1 to 15 years and 25 to 45 years, as well as in the elderly (60 to 90 years). Further analysis found that the four most frequently identified M types from blood, brain, and cerebrospinal fluid were M1 (28.2%), M28 (9.2%), M12 (9.1%), and M3 (8.2%), with 13.4% of isolates being nontypeable. The four isolates from throats most frequently identified were M1 (19.5%), M12 (15.3%), M3 (8.6%), and M28 (5%) with 19.4% of isolates being nontypeable. The sic gene of a subset of M1 strains (9.5% of the M1 collection) was sequenced. Of 36 sic types identified, the four most common were sic1.01 (22.8%), sic1.02 (14.9%), sic1.135 (10.5%), and sic1.178 (9.6%). Together these four sic types further characterized nearly 60% of the M1 strains sequenced. In summary, from the years 1993 to 1999, the NCS detected 54 M types, of which 10 different M types constituted 73.5% of the collection. M1 was the most common GAS M type circulating in the Canadian population, responsible for more than a quarter of the isolates typed. The most common throat isolates differed in M-type and proportion from those of invasive isolates. Sequencing the sic gene further characterized the most common M-type serotype 1 in a fashion that may be useful for epidemiologic investigations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454137      PMCID: PMC154642          DOI: 10.1128/JCM.40.12.4466-4471.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves.

Authors:  N P Hoe; K Nakashima; S Lukomski; D Grigsby; M Liu; P Kordari; S J Dou; X Pan; J Vuopio-Varkila; S Salmelinna; A McGeer; D E Low; B Schwartz; A Schuchat; S Naidich; D De Lorenzo; Y X Fu; J M Musser
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

2.  Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.

Authors:  D R Johnson; D L Stevens; E L Kaplan
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

3.  Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995.

Authors:  B Beall; R Facklam; T Hoenes; B Schwartz
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

4.  The use of the serum opacity reaction in the typing of group-A streptococci.

Authors:  W R Maxted; J P Widdowson; C A Fraser; L C Ball; D C Bassett
Journal:  J Med Microbiol       Date:  1973-02       Impact factor: 2.472

5.  Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells.

Authors:  Nancy P Hoe; Robin M Ireland; Frank R DeLeo; Brian B Gowen; David W Dorward; Jovanka M Voyich; Mengyao Liu; Eugene H Burns; Derek M Culnan; Anthony Bretscher; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease.

Authors:  G Colman; A Tanna; A Efstratiou; E T Gaworzewska
Journal:  J Med Microbiol       Date:  1993-09       Impact factor: 2.472

7.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

8.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

Authors:  C W Hoge; B Schwartz; D F Talkington; R F Breiman; E M MacNeill; S J Englender
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

9.  Changing epidemiology of group A streptococcal infection in the USA.

Authors:  B Schwartz; R R Facklam; R F Breiman
Journal:  Lancet       Date:  1990-11-10       Impact factor: 79.321

10.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

View more
  28 in total

1.  emm typing of M nontypeable invasive group A streptococcal isolates in Israel.

Authors:  Allon E Moses; Carlos Hidalgo-Grass; Mary Dan-Goor; Joseph Jaffe; Ilanit Shetzigovsky; Miriam Ravins; Zinaida Korenman; Ronit Cohen-Poradosu; Ran Nir-Paz
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002).

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Bertha Kress; Karen Grimsrud
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 3.  Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus.

Authors:  James M Musser; Frank R DeLeo
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

4.  Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.

Authors:  Shizhen Zhang; Nicole M Green; Izabela Sitkiewicz; Rance B Lefebvre; James M Musser
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection.

Authors:  Per Akesson; Linnea Moritz; Mikael Truedsson; Bertil Christensson; Ulrich von Pawel-Rammingen
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting.

Authors:  Karen F McGregor; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

7.  Invasive group A streptococcal disease: Management and chemoprophylaxis.

Authors:  Ud Allen; Dl Moore
Journal:  Paediatr Child Health       Date:  2010-05       Impact factor: 2.253

8.  Invasive group A streptococcal disease: Management and chemoprophylaxis.

Authors:  Ud Allen; Dl Moore
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

9.  Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.

Authors:  Waleed Nasser; Stephen B Beres; Randall J Olsen; Melissa A Dean; Kelsey A Rice; S Wesley Long; Karl G Kristinsson; Magnus Gottfredsson; Jaana Vuopio; Kati Raisanen; Dominique A Caugant; Martin Steinbakk; Donald E Low; Allison McGeer; Jessica Darenberg; Birgitta Henriques-Normark; Chris A Van Beneden; Steen Hoffmann; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

10.  Group A streptococcal genotypes from throat and skin isolates in the United Arab Emirates.

Authors:  Mubarak S Alfaresi
Journal:  BMC Res Notes       Date:  2010-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.